Multidrug-resistant tuberculosis
Authors:
- IrkhamIRIrkham
Top Cited Papers
- 1 May 2024
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 559, 119701
Abstract
No abstract availableKeywords
Funding Information
- Universitas Padjadjaran (2332/UN6.3.1/PT.00/2024)
- Universitas Padjadjaran (1957/UN6.3.1/PT.00/2024)
This publication has 111 references indexed in Scilit:
- An Update on the Application of CRISPR Technology in Clinical PracticeMolecular Biotechnology, 2023
- A Review on the Mechanism and Applications of CRISPR/Cas9/Cas12/Cas13/Cas14 Proteins Utilized for Genome EngineeringMolecular Biotechnology, 2022
- Development of DNA Bio-chip for Detection of Mutations of rpoB, embB and inhA Genes in Drug-Resistant Mycobacterium TuberculosisIndian Journal of Clinical Biochemistry, 2022
- Modern Anti-Tuberculosis Drugs and Their Classification. Part I: First-Line DrugsPharmaceutical Chemistry Journal, 2020
- Molecular Mechanisms of Drug Resistance in Mycobacterium tuberculosis: Role of Nanoparticles Against Multi-drug-Resistant Tuberculosis (MDR-TB)2020
- A Broad Application of CRISPR Cas9 in Infectious, Inflammatory and Neurodegenerative DiseasesJournal of Neuroimmune Pharmacology, 2019
- Safety and Tolerability Profile of Second-Line Anti-Tuberculosis MedicationsDrug Safety, 2015
- Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activityWorld Journal of Microbiology and Biotechnology, 2014
- Characterization of Th1- and Th2-type immune response in human multidrug-resistant tuberculosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Multidrug resistant to extensively drug resistant tuberculosis: What is next?Journal of Biosciences, 2008